These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 24548256)

  • 21. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
    Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N
    Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The putative role of the intestinal microbiota in the irritable bowel syndrome.
    Collins SM; Denou E; Verdu EF; Bercik P
    Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome].
    Kong WM; Gong J; Dong L; Xu JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1345-7. PubMed ID: 17884774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome.
    Willot S; Gauthier C; Patey N; Faure C
    Neurogastroenterol Motil; 2012 Aug; 24(8):734-9, e347. PubMed ID: 22625872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea.
    Vazquez-Roque MI; Camilleri M; Smyrk T; Murray JA; O'Neill J; Carlson P; Lamsam J; Eckert D; Janzow D; Burton D; Ryks M; Rhoten D; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1262-9. PubMed ID: 23042942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal Barrier Function in Gastrointestinal Disorders.
    Farré R; Vicario M
    Handb Exp Pharmacol; 2017; 239():193-217. PubMed ID: 27995392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overlap between irritable bowel syndrome and inflammatory bowel disease.
    Spiller RC
    Dig Dis; 2009; 27 Suppl 1():48-54. PubMed ID: 20203497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Fronzoni L; Serra M; Corinaldesi R
    Dig Dis; 2009; 27 Suppl 1():115-21. PubMed ID: 20203507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome.
    Hasler WL; Grabauskas G; Singh P; Owyang C
    Neurogastroenterol Motil; 2022 Jul; 34(7):e14339. PubMed ID: 35315179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
    Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
    Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.
    Matricon J; Meleine M; Gelot A; Piche T; Dapoigny M; Muller E; Ardid D
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1009-31. PubMed ID: 23066886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation-induced IBS-like rats.
    Li Y; Yang T; Yao Q; Li S; Fang E; Li Y; Liu C; Li W
    Neurogastroenterol Motil; 2019 May; 31(5):e13556. PubMed ID: 30740845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
    Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?
    Hughes PA; Zola H; Penttila IA; Blackshaw LA; Andrews JM; Krumbiegel D
    Am J Gastroenterol; 2013 Jul; 108(7):1066-74. PubMed ID: 23649183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens.
    Awad WA; Hess C; Hess M
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28208612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations.
    Vicario M; González-Castro AM; Martínez C; Lobo B; Pigrau M; Guilarte M; de Torres I; Mosquera JL; Fortea M; Sevillano-Aguilera C; Salvo-Romero E; Alonso C; Rodiño-Janeiro BK; Söderholm JD; Azpiroz F; Santos J
    Gut; 2015 Sep; 64(9):1379-88. PubMed ID: 25209656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.
    Vicario M; Guilarte M; Alonso C; Yang P; Martínez C; Ramos L; Lobo B; González A; Guilà M; Pigrau M; Saperas E; Azpiroz F; Santos J
    Brain Behav Immun; 2010 Oct; 24(7):1166-75. PubMed ID: 20600818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome.
    Martínez C; González-Castro A; Vicario M; Santos J
    Gut Liver; 2012 Jul; 6(3):305-15. PubMed ID: 22844557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of irritable bowel syndrome--review regarding associated infection and immune activation.
    Ishihara S; Tada Y; Fukuba N; Oka A; Kusunoki R; Mishima Y; Oshima N; Moriyama I; Yuki T; Kawashima K; Kinoshita Y
    Digestion; 2013; 87(3):204-11. PubMed ID: 23712295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
    Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.